RT Journal Article
SR Electronic
T1 Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008110
DO 10.1136/jitc-2023-008110
VO 12
IS 4
A1 Coffey, David G
A1 Osman, Keren
A1 Aleman, Adolfo
A1 Bekri, Selma
A1 Kats, Simone
A1 Dhadwal, Amishi
A1 Catamero, Donna
A1 Kim-Schulze, Seunghee
A1 Gnjatic, Sacha
A1 Chari, Ajai
A1 Parekh, Samir
A1 Jagannath, Sundar
A1 Cho, Hearn Jay
YR 2024
UL http://jitc.bmj.com/content/12/4/e008110.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.